Protein mass spectrometry experiment, immunoprecipitation, immunofluorescence, subcellular fractionation, mitochondria isolation, cycloheximide assays, and lung cancer xenograft mouse models were performed to clarify the molecular mechanism of RAB3A in NSCLC progression. The gene discussed is RAB3A; the disease is lung cancer.